Clinical trial
Cell Therapy for Coronary Heart Disease: Infusion of Autologous Ex Vivo Cultivated Endothelial Progenitor Cells (EPCs)" and Autologous Bone Marrow Progenitor Cells in Crossover Design for Improvement of Vascularization and Cardiac Function
NCT00289822 is registered in ClinicalTrials.gov with Johann Wolfgang Goethe University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cell Therapy for Coronary Heart Disease: Infusion of Autologous Ex Vivo Cultivated Endothelial Progenitor Cells (EPCs)" and Autologous Bone Marrow Progenitor Cells in Crossover Design for Improvement of Vascularization and Cardiac Function
- Lead sponsor
- Johann Wolfgang Goethe University Hospital
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- January 31, 2002
- Completion date
- January 31, 2005
- Enrollment
- 75
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.